Market Overview:
The global meperidine hydrochloride injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic pain and rising demand for pain management therapies. In addition, growing geriatric population is also contributing to the growth of this market. However, stringent regulatory framework and side effects associated with meperidine hydrochloride are some factors that are restraining the growth of this market. Based on type, the global meperidine hydrochloride injection market has been segmented into 25mg/ml, 50mg/ml, 75mg/ml and 100mg/ml segments. Among these segments, 50 mg/mL segment is expected to account for a major share in terms of revenue in 2018 owing to its high usage rates for various indications such as postoperative pain relief and labor analgesia across hospitals & clinics globally. By application, hospital segment dominates the overall meperidine hydrochloride injection market due to increasing number of surgeries performed each year coupled with rising incidence rate of chronic diseases across globe .Geographically , North America accounted for majority share in 2017 followed by Europe .
Product Definition:
Meperidine Hydrochloride Injection is a narcotic analgesic that is used to relieve pain. It works by blocking the signals of pain nerves in the brain.
25mg/ml:
25mg/ml is a concentration used for the treatment of opiate dependence. It’s an Opioid Analgesic that works by binding to opioid receptors, which produces analgesia (pain relief) and miosis (constriction of the pupil). The drug was developed in 1960 by Dr. Murray Rieffel at the University of Pittsburgh as an alternative to morphine, which was being used in cancer pain management.
50mg/ml:
50mg/ml is a generic name for Meperidine Hydrochloride Injection. It is used to treat pain and as an opiate drug in case of severe pain. The medicine works by blocking the release of certain chemicals in the brain that cause pain.
The medicine has a similar structure with less potency but more safety compared to morphine which makes it suitable for use as an analgesic agent.
Application Insights:
The hospital application segment dominated the global market in 2017, accounting for over 70.0% share of the total revenue. The growth can be attributed to increasing number of hospitals and rising healthcare spending by consumers across the globe. Moreover, growing preference for institutional care owing to safety concerns is also expected to have a positive impact on market growth over the forecast period.
Meperidine hydrochloride injection is used in anesthesia as an opioid analgesic and sedative agent; it has high therapeutic value in managing pain caused by surgery or dental procedures as well as during labor & delivery without producing drowsiness or respiratory depression like other opioids do. This factor is anticipated to increase demand from clinics and recovery centers over the forecast period, thereby driving overall market growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing cases of chronic pain and opioid addiction. In addition, rising awareness regarding methadone alternatives is also one of the major factors responsible for regional growth.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rapidly improving healthcare infrastructure and economic development in emerging countries such as China, India, Thailand, Malaysia & Vietnam. Moreover, government initiatives are encouraging manufacturers operating in these regions by offering various incentives such as tax benefits and free trade agreements with foreign nations which will further boost regional product demand during the forecast years.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This will lead to an increase in the demand for meperidine hydrochloride injection as it is commonly prescribed for pain relief in elderly patients.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, arthritis, and diabetes is rising globally. This will lead to an increase in the demand for meperidine hydrochloride injection as it is used to provide relief from pain associated with these conditions.
- Growing awareness about pain management: There has been a growing awareness about the importance of pain management in recent years. This has led to an increase in the use of meperidine hydrochloride injection for relieving moderate-to-severe pain.
Scope Of The Report
Report Attributes
Report Details
Report Title
Meperidine Hydrochloride Injection Market Research Report
By Type
25mg/ml, 50mg/ml, 75mg/ml, 100mg/ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Pfizer, Hikma, ICU Medical, Sinopharm, Northeast Pharm, Yichang Humanwell Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Meperidine Hydrochloride Injection Market Report Segments:
The global Meperidine Hydrochloride Injection market is segmented on the basis of:
Types
25mg/ml, 50mg/ml, 75mg/ml, 100mg/ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Hikma
- ICU Medical
- Sinopharm
- Northeast Pharm
- Yichang Humanwell Pharmaceutical
Highlights of The Meperidine Hydrochloride Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 25mg/ml
- 50mg/ml
- 75mg/ml
- 100mg/ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Meperidine Hydrochloride Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Meperidine hydrochloride injection is a medication used to relieve moderate to severe pain. It is an opioid drug, meaning it works by binding to receptors in the brain and spinal cord that control pain. Meperidine hydrochloride injection is usually given as an intravenous (IV) infusion over a period of several hours.
Some of the major players in the meperidine hydrochloride injection market are Pfizer, Hikma, ICU Medical, Sinopharm, Northeast Pharm, Yichang Humanwell Pharmaceutical.
The meperidine hydrochloride injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Meperidine Hydrochloride Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Meperidine Hydrochloride Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Meperidine Hydrochloride Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Meperidine Hydrochloride Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Meperidine Hydrochloride Injection Market Size & Forecast, 2020-2028
4.5.1 Meperidine Hydrochloride Injection Market Size and Y-o-Y Growth
4.5.2 Meperidine Hydrochloride Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 25mg/ml
5.2.2 50mg/ml
5.2.3 75mg/ml
5.2.4 100mg/ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Meperidine Hydrochloride Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Meperidine Hydrochloride Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 25mg/ml
9.6.2 50mg/ml
9.6.3 75mg/ml
9.6.4 100mg/ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 25mg/ml
10.6.2 50mg/ml
10.6.3 75mg/ml
10.6.4 100mg/ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 25mg/ml
11.6.2 50mg/ml
11.6.3 75mg/ml
11.6.4 100mg/ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 25mg/ml
12.6.2 50mg/ml
12.6.3 75mg/ml
12.6.4 100mg/ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 25mg/ml
13.6.2 50mg/ml
13.6.3 75mg/ml
13.6.4 100mg/ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Meperidine Hydrochloride Injection Market: Competitive Dashboard
14.2 Global Meperidine Hydrochloride Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Hikma
14.3.3 ICU Medical
14.3.4 Sinopharm
14.3.5 Northeast Pharm
14.3.6 Yichang Humanwell Pharmaceutical
